The Detection of Hepatitis Viruses

Methods in Molecular Biology

Volumn 665, Issue , 2011, Pages 79-100

  Karayiannis, Peter ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Antibody; Antigen; Elisa; Hepatitis virus; Hybridisation; Markers of infection; Molecular tests; Nucleic acid amplification; Nucleic acid detection; Nucleic acid extraction; Polymerase chain reaction; Real time PCR; RT PCR; Serological tests

Indexed keywords

VIRUS DNA;

ARTICLE; COMPARATIVE STUDY; GENETICS; HEPATITIS VIRUS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; POLYMERASE CHAIN REACTION; SEROLOGY; VIROLOGY; VIRUS HEPATITIS;

DNA, VIRAL; HEPATITIS VIRUSES; HEPATITIS, VIRAL, HUMAN; HUMANS; POLYMERASE CHAIN REACTION; SEROLOGIC TESTS;

EID: 79955809338     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-817-1_6     Document Type: Chapter

References (24)

1. Karayiannis, P., Main, J., and Thomas, H.C. (2004) Hepatitis vaccines. Br Med Bull 70, 29–49.
2. Nainan, O.V., Xia, G., Vaughan, G., and Margolis, H.S. (2006) Diagnosis of hepatitis A virus infection: a molecular approach. Clin Microbiol Rev 19, 63–79.
3. Costa-Mattioli, M., Di Napoli, A., Ferré, V., Billaudel, S., Perez-Bercoff, R., and Cristina, J. Genetic variability of hepatitis A virus. J Gen Virol 84, 3191–3201.
4. Ping, L.H., Jansen, R.W., Stapleton, J.T., Cohen, J.I., and Lemon, S.M. (1988) Identification of an immunodominant antigenic site involving the capsid protein VP3 of hepatitis A virus. Proc Natl Acad Sci USA 85, 8281–8285.
5. Ganem, D. and Prince, A.M. (2004) Hepatitis B virus infection – natural history and clinical consequences. N Engl J Med 350, 118–129.
6. Karayiannis, P., Carman, W.F., and Thomas, H.C. (2005) Molecular variations in the core promoter, precore and core regions of hepatitis B virus, and their clinical significance. In: Thomas, H.C., Lemon, S., and Zuckerman, A.J. Ed. Viral Hepatitis. Blackwell, London, pp. 242–262.
7. Lok, A.S. (2007) Navigating the maze of hepatitis B treatments. Gastroenterology 132, 1586–1594.
8. Carman, W.F., Jazayeri, M., Basune, A., Thomas, H.C., and Karayiannis, P. (2005) Hepatitis B surface antigen (HBsAg) variants. In: Thomas, H.C., Lemon, S., and Zuckerman, A.J. Ed. Viral Hepatitis. Blackwell, London, pp. 225–241.
9. Moradpour, D., Penin, F., and Rice, C.M. (2007) Replication of hepatitis C virus. Nat Rev Microbiol 5, 453–463.
10. Foster, G. and Mathurin, P. (2008) Hepatitis C virus therapy to date. Antivir Ther 13(Suppl 1), 3–8.
11. Simmonds, P., Bukh, J., Combet, C., Deléage, G., Enomoto, N., Feinstone, S., Halfon, P., Inchauspé, G., Kuiken, C., Maertens, G., Mizokami, M., Murphy, D.G., Okamoto, H., Pawlotsky, J.M., Penin, F., Sablon, E., Shin-I, T., Stuyver, L.J., Thiel, H.J., Viazov, S., Weiner, A.J., and Widell, A. (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42, 962–973.
12. Taylor, J.M. (2006) Hepatitis delta virus. Virology 344, 71–76.
13. Dény P. (2006) Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades? Curr Top Microbiol Immunol 307, 151–171.
14. Mushahwar, I.K. (2008) Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J Med Virol 80, 646–658.
15. Okamoto H. (2007) Genetic variability and evolution of hepatitis E virus. Virus Res 127, 216–228.
16. Karayiannis, P., Alexopoulou, A., Hadziyannis, S., Thursz, M., Watts, R., Seito, S., and Thomas, H.C. (1995) Fulminant hepatitis associated with hepatitis B virus e antigen-negative infection: importance of host factors. Hepatology 22, 1628–1634.
17. Carman, W.F., Jacyna, M.R., Hadziyannis, S., Karayiannis, P., McGarvey, M., Makris, A., and Thomas, H.C. (1989) Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet ii, 588–591.
18. Carman, W.F., Zanetti, A.R., Karayiannis, P., Manzillo, G., Tanzi, E., Zuckerman, A.J., and Thomas, H.C. (1990) A vaccine induced escape mutant of hepatitis B virus. Lancet ii, 325–329.
19. Seddigh-Tonekaboni, S., Waters, J.A., Jeffers, S., Gehrke, R., Ofenloch, B., Horsch, A., Hess, G., Thomas, H.C., and Karayiannis, P. (2000) The effect of variation in the common “a” determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 60, 113–121.
20. Yamashiro, T., Nagayama, K., Enomoto, N., Watanabe, H., Miyagi, T., Nakasone, H., Sakugawa, H., and Watanabe, M. (2004) Quantitation of the level of hepatitis delta virus RNA in serum, by real-time polymerase chain reaction – and its possible correlation with the clinical stage of liver disease. J Infect Dis 189, 1151–1157.
21. Gyarmati, P., Mohammed, N., Norder, H., Blomberg, J., Belák, S., and Widén, F. (2007) Universal detection of hepatitis E virus by two real-time PCR assays: TaqMan and primer-probe energy transfer. J Virol Methods 146, 226–235.
22. Sarrazin, C. (2002) Highly sensitive hepatitis C virus RNA detection methods: molecular backgrounds and clinical significance. J Clin Virol 25(Suppl 3), 23–29.
23. Bartholomeusz, A. and Locarnini, S.A. (2006) Antiviral drug resistance: clinical consequences and molecular aspects. Semin Liver Dis 26, 162–170.
24. Jensen, D.M. and Ascione, A. (2008) Future directions in therapy for chronic hepatitis C. Antivir Ther 3(Suppl 1), 31–36.